# Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism

Study · id `cardio:ct-nct03044574` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03044574](<https://clinicaltrials.gov/study/NCT03044574>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03044574

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 407 participants.

## Technical summary

Registry record NCT03044574. Randomized; single masking; primary purpose prevention. Start 2017-02-01 (actual); primary completion 2018-09-30 (actual). Results posted on 2020-02-05.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 407 participants (enrolled count; ClinicalTrials.gov record NCT03044574, source copy `cardio:ctgov-nct03044574-2021-02-04`, retrieved 2026-10-31)
- Started: 2017-02-01 (actual) (ClinicalTrials.gov record NCT03044574, source copy `cardio:ctgov-nct03044574-2021-02-04`, retrieved 2026-10-31)
- Primary completion: 2018-09-30 (actual) (ClinicalTrials.gov record NCT03044574, source copy `cardio:ctgov-nct03044574-2021-02-04`, retrieved 2026-10-31)
- Completion: 2018-12-31 (actual) (ClinicalTrials.gov record NCT03044574, source copy `cardio:ctgov-nct03044574-2021-02-04`, retrieved 2026-10-31)
- Results first posted: 2020-02-05 (ClinicalTrials.gov record NCT03044574, source copy `cardio:ctgov-nct03044574-2021-02-04`, retrieved 2026-10-31)
- Countries: Russia (ClinicalTrials.gov record NCT03044574, source copy `cardio:ctgov-nct03044574-2021-02-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03044574-2021-02-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism
- Acronym: IPCSUPER
- Condition: Venous Thromboembolism
- Condition: Venous Thrombosis
- Intervention (Device): SCD
- Intervention (Device): GCS
- Intervention (Drug): LMWH
- Lead sponsor: Pirogov Russian National Research Medical University
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry intervention name matches this record: Heparins and low-molecular-weight heparins (`cardio:heparins-and-low-molecular-weight-heparins`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study (`cardio:pubmed-32348101`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intermittent Pneumatic Compression in Addition to Standard Prophylaxis of Postoperative Venous Thromboembolism in Extremely High-risk Patients (IPC SUPER): A Randomized Controlled Trial (`cardio:pubmed-33201130`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7e6fae7e2873049dc18defb5bff30a8ac36bca441798c62a7f24a0768b2368bb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
